Half Yearly Progress Report - For the Period Ended 31 December 2025 - 17/04/2026
Filed with PSX · · 9 pages · English
Summary by 6ix AI
The report includes a certificate from auditors KPMG Taseer Hadi & Co. regarding the implementation status of the planned projects funded by the IPO. It outlines the status of various machinery purchases and certifications, highlighting both completed and ongoing projects. The report also provides a summary of funds utilized and remaining for each purpose outlined in the IPO prospectus.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from BF Biosciences
- Resignation of Director
- Transmission of Quarterly Financial Statements for the Period Ended 31-12-2025
- Decisions of Emergent Board of Directors Meeting Held On Dec 19, 2025
- Financial Results for the Quarter Ended 2025-09-30
- Financial Results for the Year Ended 30-06-2025
Later from BF Biosciences
- Financial Results for the Quarter Ended 31-03-2026 - 28/04/2026
- Transmission of Quarterly Report for the Period Ended 31-03-2026 - 30/04/2026
- Appointment of Director to Fill Casual Vacancy
- Appointment of Director to Fill Casual Vacancy - 01/06/2026
- Intimation of Passing Away of Mrs. Akhter Khalid Waheed, Director and Founding CEO - 02/06/2026
Follow BF Biosciences into a list and get an email when it puts out news.
Follow BF Biosciences